Caspase Activity and Apoptosis Inhibitor 1 (CAAP1) (Middle Region) anticorps
Aperçu rapide pour Caspase Activity and Apoptosis Inhibitor 1 (CAAP1) (Middle Region) anticorps (ABIN5517860)
Antigène
Tous les produits Caspase Activity and Apoptosis Inhibitor 1 (CAAP1)Reactivité
Hôte
Clonalité
Application
-
-
Épitope
- Middle Region
-
Séquence
- GSVSCCGNAN FSGSVTGGGS GGSCWGGSSV ERSERRKRRS TDSSSVSGSL
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the middle region of human CAAP1
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 23 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- Caspase Activity and Apoptosis Inhibitor 1 (CAAP1)
-
Autre désignation
- CAAP1
-
Sujet
-
Alias Symbols: CAAP, C9orf82
Protein Size: 361 -
ID gène
- 79886
-
NCBI Accession
- NM_001167575, NP_001161047
-
UniProt
- Q9H8G2
Antigène
-